Antisense technology for cancer therapy: does it make sense?
ICRF Oncology Group, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.
G
G
Carter
N R
NR
Lemoine
D001483:Base Sequence; D016373:DNA, Antisense / Q000627:therapeutic use*; D006801:Humans; D006860:Hydrogen Bonding; D008969:Molecular Sequence Data; D009369:Neoplasms / Q000628:therapy*; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use; D016372:RNA, Antisense / Q000627:therapeutic use*; D016337:RNA, Catalytic / Q000627:therapeutic use; D013329:Structure-Activity Relationship
D016373:DNA, Antisense; D016376:Oligonucleotides, Antisense; D016372:RNA, Antisense; D016337:RNA, Catalytic